|
1
|
Ansari MH: Salivary gland tumors in an
Iranian population: a retrospective study of 130 cases. J Oral
Maxillofac Surg. 65:2187–2194. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ma’aita JK, Al-Kaisi N, Al-Tamimi S and
Wraikat A: Salivary gland tumors in Jordan: a retrospective study
of 221 patients. Croat Med J. 40:539–542. 1999.PubMed/NCBI
|
|
3
|
Jaber MA: Intraoral minor salivary gland
tumors: a review of 75 cases in a Libyan population. Int J Oral
Maxillofac Surg. 35:150–154. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tian Z, Li L, Wang L, Hu Y and Li J:
Salivary gland neoplasms in oral and maxillofacial regions: a
23-year retrospective study of 6982 cases in an eastern Chinese
population. Int J Oral Maxillofac Surg. 39:235–242. 2010.PubMed/NCBI
|
|
5
|
McHugh CH, Roberts DB, El-Naggar AK, et
al: Prognostic factors in mucoepidermoid carcinoma of the salivary
glands. Cancer. 118:3928–3936. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chiosea SI, Barnes EL, Lai SY, et al:
Mucoepidermoid carcinoma of upper aerodigestive tract:
clinicopathologic study of 78 cases with immunohistochemical
analysis of Dicer expression. Virchows Arch. 452:629–635. 2008.
View Article : Google Scholar
|
|
7
|
Mariano FV, da Silva SD, Chulan TC, de
Almeida OP and Kowalski LP: Clinicopathological factors are
predictors of distant metastasis from major salivary gland
carcinomas. Int J Oral Maxillofac Surg. 40:504–509. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miyabe S, Okabe M, Nagatsuka H, et al:
Prognostic significance of p27Kip1, Ki-67 and CRTC1-MAML2 fusion
transcript in mucoepidermoid carcinoma: a molecular and
clinicopathologic study of 101 cases. J Oral Maxillofac Surg.
67:1432–1441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhaskaran M, Wang Y, Zhang H, et al:
MicroRNA-127 modulates fetal lung development. Physiol Genomics.
37:268–278. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pauley KM, Stewart CM, Gauna AE, et al:
Altered miR-146a expression in Sjogren’s syndrome and its
functional role in innate immunity. Eur J Immunol. 41:2029–2039.
2011.PubMed/NCBI
|
|
12
|
Hayashi T, Koyama N, Azuma Y and Kashimata
M: Mesenchymal miR-21 regulates branching morphogenesis in murine
submandibular gland in vitro. Dev Biol. 352:299–307. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F,
Shen Y, Lu W, Wan X and Xie X: miR-375 is down-regulated in
squamous cervical cancer and inhibits cell migration and invasion
via targeting transcription factor SP1. Am J Pathol. 179:2580–2588.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang
X, Jiang L, Sun Z, Miao Z and Xu H: MicroRNA-335 acts as a
metastasis suppressor in gastric cancer by targeting Bcl-w and
specificity protein 1. Oncogene. 31:1398–1407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He L and Hannon GJ: MicroRNAs: small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li B, Shi XB, Nori D, et al:
Down-regulation of microRNA 106b is involved in p21-mediated cell
cycle arrest in response to radiation in prostate cancer cells.
Prostate. 71:567–574. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sempere LF, Freemantle S, Pitha-Rowe I,
Moss E, Dmitrovsky E and Ambros V: Expression profiling of
mammalian microRNAs uncovers a subset of brain-expressed microRNAs
with possible roles in murine and human neuronal differentiation.
Genome Biol. 5:R132004. View Article : Google Scholar
|
|
19
|
Sassen S, Miska EA and Caldas C: MicroRNA:
implications for cancer. Virchows Arch. 452:1–10. 2008. View Article : Google Scholar
|
|
20
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Su H, Yang JR, Xu T, et al: MicroRNA-101,
down-regulated in hepatocellular carcinoma, promotes apoptosis and
suppresses tumorigenicity. Cancer Res. 69:1135–1142. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song YX, Yue ZY, Wang ZN, et al:
MicroRNA-148b is frequently down-regulated in gastric cancer and
acts as a tumor suppressor by inhibiting cell proliferation. Mol
Cancer. 10:12011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nadiminty N, Tummala R, Lou W, et al:
MicroRNA let-7c is downregulated in prostate cancer and suppresses
prostate cancer growth. PLoS One. 7:e328322012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nie J, Liu L, Zheng W, et al:
microRNA-365, down-regulated in colon cancer, inhibits cell cycle
progression and promotes apoptosis of colon cancer cells by
probably targeting Cyclin D1 and Bcl-2. Carcinogenesis. 33:220–225.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He XY, Chen JX, Zhang Z, Li CL, Peng QL
and Peng HM: The let-7a microRNA protects from growth of lung
carcinoma by suppression of k-Ras and c-Myc in nude mice. J Cancer
Res Clin Oncol. 136:1023–1028. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Long XB, Sun GB, Hu S, et al: Let-7a
microRNA functions as a potential tumor suppressor in human
laryngeal cancer. Oncol Rep. 22:1189–1195. 2009.PubMed/NCBI
|
|
27
|
Johnson SM, Grosshans H, Shingara J, et
al: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsai WC, Hsu PW, Lai TC, et al:
MicroRNA-122, a tumor suppressor microRNA that regulates
intrahepatic metastasis of hepatocellular carcinoma. Hepatology.
49:1571–1582. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee KH, Chen YL, Yeh SD, et al:
MicroRNA-330 acts as tumor suppressor and induces apoptosis of
prostate cancer cells through E2F1-mediated suppression of Akt
phosphorylation. Oncogene. 28:3360–3370. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yan LX, Huang XF, Shao Q, et al: MicroRNA
miR-21 overexpression in human breast cancer is associated with
advanced clinical stage, lymph node metastasis and patient poor
prognosis. RNA. 14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saito Y, Liang G, Egger G, et al: Specific
activation of microRNA-127 with downregulation of the
proto-oncogene BCL6 by chromatin-modifying drugs in human cancer
cells. Cancer Cell. 9:435–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang C, Wang C, Chen X, et al: Expression
profile of microRNAs in serum: a fingerprint for esophageal
squamous cell carcinoma. Clin Chem. 56:1871–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsai KW, Wu CW, Hu LY, et al: Epigenetic
regulation of miR-34b and miR-129 expression in gastric cancer. Int
J Cancer. 129:2600–2610. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tryndyak VP, Ross SA, Beland FA and
Pogribny IP: Down-regulation of the microRNAs miR-34a, miR-127 and
miR-200b in rat liver during hepatocarcinogenesis induced by a
methyl-deficient diet. Mol Carcinog. 48:479–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Duan Z, Choy E, Harmon D, et al:
MicroRNA-199a-3p is downregulated in human osteosarcoma and
regulates cell proliferation and migration. Mol Cancer Ther.
10:1337–1345. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wei D, Wang L, He Y, Xiong HQ, Abbruzzese
JL and Xie K: Celecoxib inhibits vascular endothelial growth factor
expression in and reduces angiogenesis and metastasis of human
pancreatic cancer via suppression of Sp1 transcription factor
activity. Cancer Res. 64:2030–2038. 2004. View Article : Google Scholar
|
|
37
|
Wang L, Wei D, Huang S, et al:
Transcription factor Sp1 expression is a significant predictor of
survival in human gastric cancer. Clin Cancer Res. 9:6371–6380.
2003.PubMed/NCBI
|
|
38
|
Choi ES, Shim JH, Jung JY, et al:
Apoptotic effect of tolfenamic acid in androgen
receptor-independent prostate cancer cell and xenograft tumor
through specificity protein 1. Cancer Sci. 102:742–748. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shim JH, Shin JA, Jung JY, et al:
Chemopreventive effect of tolfenamic acid on KB human cervical
cancer cells and tumor xenograft by downregulating specificity
protein 1. Eur J Cancer Prev. 20:102–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shin JA, Shim JH, Jeon JG, et al:
Apoptotic effect of Polygonum Cuspidatum in oral cancer
cells through the regulation of specificity protein 1. Oral Dis.
17:162–170. 2011.
|
|
41
|
Xiong Y, Fang JH, Yun JP, et al: Effects
of microRNA-29 on apoptosis, tumorigenicity and prognosis of
hepatocellular carcinoma. Hepatology. 51:836–845. 2010.PubMed/NCBI
|
|
42
|
Liu X, Jiang L, Wang A, Yu J, Shi F and
Zhou X: MicroRNA-138 suppresses invasion and promotes apoptosis in
head and neck squamous cell carcinoma cell lines. Cancer Lett.
286:217–222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cimmino A, Calin GA, Fabbri M, et al:
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
